Skip to main content
S 3558 118th Congress Senate Government Operations and Politics Congressional oversight Government information and archives Health technology, devices, supplies Public contracts and procurement

Prohibiting Foreign Access to American Genetic Information Act of 2024

Introduced: May 23, 2024 Introduced by: Peters, Gary C. Democratic · Michigan See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 23, 2024
Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.
Sep 23, 2024
Committee on Homeland Security and Governmental Affairs. Reported by Senator Peters with an amendment in the nature of a substitute. With written report No. 118-229.
Mar 6, 2024
Committee on Homeland Security and Governmental Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
Dec 20, 2023
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Dec 20, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill prohibits federal contracting with certain biotechnology providers connected to foreign adversaries, with exceptions.

Specifically, the bill prohibits executive agencies from (1) procuring or obtaining any biotechnology equipment or service produced or provided by a biotechnology company of concern, or (2) entering into a contract or extending or renewing a contract that uses such equipment or service or that will require the direct use of such equipment or services. Those agencies may not obligate or expend loan or grant funds for such purposes.

A biotechnology company of concern includes BGI, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of such entities, and any entity that

  • is subject to the jurisdiction, direction, control, or operates on behalf of the government of a foreign adversary;
  • is involved in the manufacturing, distribution, provision, or procurement of a biotechnology equipment or service; and
  • poses a risk to U.S. national security based on specified activities.

Executive agencies may waive the prohibitions on a case-by-case basis under specified circumstances.

The Office of Management and Budget must develop and periodically update a list of the entities that constitute biotechnology companies of concern.

What's happening now September 23, 2024

Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.

 Related & companion bills 1
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 3

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Cite this page click to expand
APA
U.S. Congress. (2026). S. 3558: Prohibiting Foreign Access to American Genetic Information Act of 2024. 118th Congress. Open America. https://openamerica.io/bill/118-S-3558/
MLA
"S. 3558: Prohibiting Foreign Access to American Genetic Information Act of 2024." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-3558/.
Bluebook (legal)
S. 3558, 118th Cong. (2026), https://openamerica.io/bill/118-S-3558/.
Markdown link
[S. 3558: Prohibiting Foreign Access to American Genetic Information Act of 2024](https://openamerica.io/bill/118-S-3558/)
Report a problem